Wound healing by topical application of antioxidant iron chelators: Kojic acid and deferiprone

International Wound Journal

Volumn 10, Issue 3, 2013, Pages 260-264

  Mohammadpour, Mehrdad ^a   Behjati, Mohaddeseh ^a   Sadeghi, Amir ^a   Fassihi, Afshin ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Deferiprone; Iron chelator; Kojic acid; Wound healing

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ASCORBIC ACID; DEFERIPRONE; FREE RADICAL; KOJIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; IC 50; IN VIVO STUDY; IRON CHELATION; NONHUMAN; PRIORITY JOURNAL; RAT; TOPICAL TREATMENT; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; IRON CHELATING AGENTS; MYCOTOXINS; PYRIDONES; PYRONES; RATS; RATS, WISTAR; SKIN ULCER; TREATMENT OUTCOME; WOUND HEALING;

EID: 84878128952     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.00971.x     Document Type: Article

References (29)

1. Ramos R, Silva JP, Rodrigues AC, Costa R, Guardão L, Schmitt F, Soares R, Vilanova M, Domingues L, Gama M. Wound healing activity of the human antimicrobial peptide LL37. Peptides 2011;32:1469-76.
2. Chaturvedi AP, Tripathi YB. Methanolic extract of leaves of Jasminum grandiflorum Linn modulates oxidative stress and inflammatory mediators. Inflammopharmacology 2011;19:273-81.
3. Rao MC, Sudheendra AT, Nayak PG, Paul P, Kutty GN, Shenoy RR. Effect of dehydrozingerone, a half analog of curcumin on dexamethasone-delayed wound healing in albino rats. Mol Cell Biochem 2011;355:249-56.
4. Isaya G, O'Neill HA, Gakh O, Park S, Mantcheva R, Mooney SM. Functional studies of frataxin. Acta Paediatr Suppl 2004;93:68-73.
5. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, Weiss JM, Wlaschek M, Sunderkötter C, Scharffetter-Kochanek K. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011;121:985-97.
6. Jacob AK, Hotchkiss RS, DeMeester SL, Hiramatsu M, Karl IE, Swanson PE, Cobb JP, Buchman TG. Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery 1997;122:243-54.
7. Ekuni D, Firth JD, Nayer T, Tomofuji T, Sanbe T, Irie K, Yamamoto T, Oka T, Liu Z, Vielkind J, Putnins EE. Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model. Am J Pathol 2009;175:1398-409.
8. Mertz PM, Ovington LG. Wound healing microbiology. Dermatol Clin 1993;11:739-47.
9. MacKay D, Miller A. Nutritional support for wound healing. Altern Med Rev 2003;8:359-72.
10. Karodi R, Jadhav M, Rub R, Bafna A. Evaluation of the wound healing activity of a crude extract of Rubia cordifolia L. (Indian madder) in mice. Int J Appl Res Nat Prod 2009;2:12-8.
11. Gupta A, Singh RL, Raghubir R. Antioxidant status during cutaneous wound healing in immunocompromised rats. Mol Cell Biochem 2002;241:1-2.
12. Ward CG. Iron and immunologic function. J Burn Care Rehabil 1987;8:487-91.
13. Farmaki K, Tzoumari I, Pappa C. Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications. Blood Cells Mol Dis 2011;47:33-40.
14. Hsu S. Green tea and the skin. J Am Acad Dermatol 2005;52:1049-59.
15. Denisov E, Afanas'ev I. Oxidation and antioxidants in organic chemistry and biology. Boca Raton, London, New York, Singapore: CBC, Taylor & Francis Group, 2005.
16. Galey JB. Potential use of iron chelators against oxidative damage. Adv Pharmacol 1996;38: 167-203.
17. Panich U, Tangsupa-a-nan V, Onkoksoong T, Kongtaphan K, Kasetsinsombat K, Akarasereenont P, Wongkajornsilp A. Inhibition of UVA-mediated melanogenesis by ascorbic acid through modulation of antioxidant defense and nitric oxide system. Arch Pharm Res 2011;34:811-20.
18. Gomes AJ, Lunardi CN, Gonzalez S, Tedesco AC. The antioxidant action of polypodium leucotomos extract and kojic acid: reactions with reactive oxygen species. Braz J Med Biol Res 2001;34:1487-94.
19. Leyden JJ, Shergill B, Micali G, Downie J, Wallo W. Natural options for the management of hyperpigmentation. J Eur Acad Dermatol Venereol 2011;25:1140-5.
20. Kotyzová D, Eybl V, Koutenský J, Brtko J, Glattre E. Effects of kojic acid on oxidative damage and on iron and trace element level in iron-overloaded mice and rats. Cent Eur J Public Health 2004;12:S41-4.
21. Aytemir MD, Hider RC, Erol DD, Ozalp M, Ekizoglu M. Synthesis of new antimicrobial agents; amide derivatives of pyranones and pyridinones. Turk J Chem 2003;27:445-52.
22. Aytemir MD, Erol DD, Hider RC, Ozalp M. Synthesis and evaluation of antimicrobial activity of new 3-hydroxy-6-methyl-4-oxo-4H -pyran-2-carboxamide derivatives. Turk J Chem 2003;27:757-64.
23. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Andersen FA. Final report of the safety assessment of kojic acid as used in cosmetics. Int J Toxicol 2010;29:244S-73S.
24. Ou J, Walczysko P, Kucerova R, Rajnicek AM, McCaig CD, Zhao M, Collinson JM. Chronic wound state exacerbated by oxidative stress in Pax6+/- aniridia-related keratopathy. J Pathol 2008;215:421-30.
25. Rodrigues AP, Carvalho AS, Santos AS, Alves CN, do Nascimento JL, Silva EO. Kojic acid, a secondary metabolite from Aspergillus sp., acts as an inducer of macrophage activation. Cell Biol Int 2011;35:335-43.
26. Fassihi A, Abedi D, Saghaie L, Sabet R, Fazeli H, Bostaki G, Deilami O, Sadinpour H. Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives. Eur J Med Chem 2009;44:2145-57.
27. Kim CM, Shin SH. Effect of iron-chelator deferiprone on the in vitro growth of staphylococci. J Korean Med Sci 2009;24:289-95.
28. Ibrahim AS, Edwards JE Jr, Fu Y, Spellberg B. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother 2006;58:1070-3.
29. Shunmugaperumal T. Polymer-based antimicrobial delivery carriers in: biofilm eradication and prevention: a pharmaceutical approach to medical device infections. Hoboken, NJ: Wiley, 2010:393.